StockData
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30
$1.64+0.02 (+1.23%)

Close on Nov 17, 2026Market cap $11.80MP/E 1.1Yield –

Chemomab Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Chemomab Therapeutics's price to book ratio was 1.1× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 2.9×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×+0.2
2025Dec 31, 20250.9×−1.7
2024Dec 31, 20242.6×+2.3
2023Dec 29, 20230.3×−0.5
2022Dec 30, 20220.8×−0.4
2021Dec 31, 20211.2×−13.6
2020Dec 31, 202014.8×+8.6
2019Dec 31, 20196.2×–

More Chemomab Therapeutics figures

See a number that looks wrong?